In 2025, Atrend Ltd strategically positioned itself across multiple dimensions in the capital markets, adapting to the reshaping global landscape. Guided by Goldman Sachs’ 2025 U.S. stock strategy, the company has established a comprehensive development ecosystem encompassing AI commercialization, biotechnology and healthcare innovation, and diversified trading services. Through technological expertise and capital empowerment, Atrend Ltd is building a sustainable value growth platform for investors.

In the field of AI, Atrend Ltd closely follows the “Mag 7” tech giants highlighted by Goldman Sachs, focusing on the core opportunities of the third phase of AI commercialization. The company continues to invest in intelligent software R&D and product innovation. By strengthening its merger and acquisition strategy, Atrend Ltd actively integrates technological resources from startups and small-to-medium-sized innovative enterprises, building a robust AI industry ecosystem. Simultaneously, it delves into high-growth small and mid-cap market segments, adopting a “low-cost, high-risk tolerance” strategy to optimize industrial collaboration and foster the deep integration of technological R&D and revenue generation capabilities.

The biotechnology and healthcare sector has become another critical growth driver. In collaboration with Goldman Sachs Group, Atrend Ltd launched the “Global Healthcare Innovation Initiative,” focusing on six major investment opportunities: vaccine and innovative drug development, precision medicine, smart medical devices, and public health advancement. The initiative prioritizes cutting-edge areas such as gene therapy, cancer immunotherapy, and regenerative medicine. Leveraging Atrend Ltd’s industry research data and Goldman Sachs’ capital operation expertise, the two parties will jointly build an industry chain ecosystem covering R&D, production, and sales. This collaboration aims to facilitate the listing and financing of innovative enterprises, helping investors capture growth opportunities in the post-pandemic healthcare industry.

At the trading services level, Atrend Ltd has officially opened primary stock market accounts, providing members with pre-market trading and IPO subscription access. This move breaks down barriers that typically prevent ordinary investors from participating in the primary market. The accompanying professional training system covers core areas such as investment fundamentals, technical analysis, and risk control. Combined with one-on-one investment advisory services and a “Learn-Invest-Reward” incentive mechanism, it helps members achieve both knowledge accumulation and financial gains. Additionally, the company has optimized risk management and asset allocation, referencing Goldman Sachs’ recommended overweight sectors to ensure stable operations amid market volatility.

A representative of Atrend Ltd stated that the company will continue to deepen its focus on AI and healthcare in the future. Through technological innovation, industrial integration, and service upgrades, Atrend Ltd aims to create a more resilient value growth space for investors and partners, contributing to the intelligent upgrading and healthy development of the global capital markets.